InnoCare Pharma Limited (9969.HK) HKSE

14.36

-0.08(-0.55%)

Updated at December 05 04:09PM

Currency In HKD

Valuation

Market Cap9.72B
Enterprise Value4.77B
P/E Ratio-75.58
PEG Ratio-3.4
Price/Sales Ratio14.72
Price/Book Ratio2.36
Enterprise/Revenue10.6
Enterprise/EBITDA-50.4

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.16
Operating Margin0.18

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.03

Income Statement

Revenue1.01B
Revenue/Share1.09
Gross Profit871.01M
EBITDA-463.49M
Net Income-440.63M
Diluted EPS-0.26

Balance Sheet

Total Cash7.06B
Total Cash/Share5.76
Total Debt1.54B
Total Debt/Equity0.23
Current Ratio7.66
Book Value Per Share5.54

Price History

52-Week Change114.5
52-Week High20.62
52-Week Low5.02
Moving Average 50 Days15.19
Moving Average 200 Days13.5

Statistics

Average Volume12.82M
Shares Outstanding1.49B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-1.81
Last Split FactorN/A
Last Split DateN/A